Rare diseases
Investigational molecules
Locations
Back to Italy2 668 clinical trials in Ranica, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of TAS3351 for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations
ItalyStudy of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease
ItalyStudy on the Safety and Effectiveness of ALLO-501A and ALLO-647 for Adults with Relapsed or Refractory Large B-Cell Lymphoma
ItalyStudy of Pembrolizumab, Vibostolimab, and Favezelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG Therapy
ItalyStudy on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients
ItalyStudy on Volixibat for Treating Itching in Patients with Primary Sclerosing Cholangitis
ItalyStudy of BMS-986442 and Nivolumab, Alone or with Chemotherapy, for Patients with Advanced Solid Tumors and Non-Small Cell Lung Cancer
ItalyStudy of Obexelimab for Patients with Warm Autoimmune Hemolytic Anemia
ItalyStudy on the Effectiveness of Citicoline Eye Drops for Visual Field Preservation in Patients with Open Angle Glaucoma
ItalyStudy of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy
ItalyStudy on Linsitinib for Patients with Active, Moderate to Severe Thyroid Eye Disease
ItalyStudy of SLN124 for Patients with Polycythemia Vera
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on membranoproliferative glomerulonephritis and related conditions, evaluating novel therapeutic approaches including iptacopan and pegcetacoplan for treating various forms of kidney inflammation.
Multiple trials aim to reduce proteinuria and improve long-term kidney function outcomes.
Comprehensive studies examining treatments for IgA Nephropathy and membranous nephropathy, including investigations of sparsentan and specialized antibody therapies for patients resistant to conventional treatments.
Focus on proteinuria reduction and preservation of renal function in various nephropathy types.
Advanced research into non-diabetic chronic kidney disease, exploring new therapeutic options including finerenone and investigating treatments for complications like hyperkalemia.
Studies aim to delay disease progression and improve standard of care outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
